Volume 11 Issue 2
Mar.  2020
Turn off MathJax
Article Contents
Pan Tianzhong, Tang Baolin, Zhu Xiaoyu, et al. Effect of pretransplant iron overload on clinical efficacy of allogeneic hematopoietic stem cell transplantation on severe aplastic anemia[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 234-239. doi: 10.3969/j.issn.1674-7445.2020.02.008
Citation: Pan Tianzhong, Tang Baolin, Zhu Xiaoyu, et al. Effect of pretransplant iron overload on clinical efficacy of allogeneic hematopoietic stem cell transplantation on severe aplastic anemia[J]. ORGAN TRANSPLANTATION, 2020, 11(2): 234-239. doi: 10.3969/j.issn.1674-7445.2020.02.008

Effect of pretransplant iron overload on clinical efficacy of allogeneic hematopoietic stem cell transplantation on severe aplastic anemia

doi: 10.3969/j.issn.1674-7445.2020.02.008
More Information
  • Corresponding author: Sun Zimin, Email: zmsun_vip@163.com
  • Received Date: 2019-12-17
    Available Online: 2021-01-19
  • Publish Date: 2020-03-15
  •   Objective  To evaluate the effect of pretransplant iron overload on the clinical efficacy of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in patients with severe aplastic anemia (SAA).  Methods  Clinical data of 80 SAA recipients who underwent allo-HSCT for the first time were retrospectively analyzed. According to the incidence of iron overload, all recipients were divided into the iron overload group (n=20) and non-iron overload group (n=60). The engraftment rate, incidence of postoperative complications and clinical prognosis of the recipients afterallo-HSCT were statistically compared between two groups. The influencing factors of 2-year overall survival (OS) and 180 d transplantation related mortality (TRM) were analyzed by Cox proportional hazards regression model.  Results  The engraftment rate of neutrophils in the non-iron overload group was 98% (59/60), significantly higher than 75% (15/20) in the iron overload group (P < 0.05). The engraftment rate of platelet in the non-iron overload group was 90% (54/60), significantly higher than 65% (13/20) in the iron overload group (P < 0.05). The incidence rate of bloodstream infection in the non-iron overload group was 23% (14/60), remarkably lower than 40% (8/20) in the iron overload group (P < 0.05). The 180 d TRM of the recipients in the non-iron overload group was 17%, significantly lower than 45% in the iron overload group (P < 0.05). The 1- and 2-year OS of the recipients in the non-iron overload group were 82% and 80%, significantly higher than 50% and 44% in the iron overload group (both P < 0.05). Iron overload or not was an independent risk factor of the OS and TRM of the recipients (both P < 0.05).  Conclusions  Iron overload can affect the OS and TRM of SAA patients after allo-HSCT.

     

  • loading
  • [1]
    GEORGES GE, DONEY K, STORB R. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment[J]. Blood Adv, 2018, 2(15):2020-2028. DOI: 10.1182/bloodadvances.2018021162.
    [2]
    PESLAK SA, OLSON T, BABUSHOK DV. Diagnosis and treatment of aplastic anemia[J]. Curr Treat Options Oncol, 2017, 18(12):70. DOI: 10.1007/s11864-017-0511-z.
    [3]
    XU LP, WANG SQ, MA YR, et al. Who is the best haploidentical donor for acquired severe aplastic anemia? experience from a multicenter study[J]. J Hematol Oncol, 2019, 12(1):87. DOI: 10.1186/s13045-019-0775-9.
    [4]
    LEE SE, YAHNG SA, CHO BS, et al. Impact of pretransplant red cell transfusion on outcome after allogeneic stem cell transplantation in adult patients with severe aplastic anemia[J]. Bone Marrow Transplant, 2016, 51(10):1323-1329. DOI: 10.1038/bmt.2016.140.
    [5]
    KILLICK SB, BOWN N, CAVENAGH J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia[J]. Br J Haematol, 2016, 172(2):187-207. DOI: 10.1111/bjh.13853.
    [6]
    LIU HL, SUN ZM, GENG LQ, et al. Unrelated cord blood transplantation for newly diagnosed patients with severe acquired aplastic anemia using a reduced-intensity conditioning: high graft rejection, but good survival[J]. Bone Marrow Transplant, 2012, 47(9):1186-1190. DOI: 10.1038/bmt.2011.251.
    [7]
    LEE JW, YOON SS, SHEN ZX, et al. Iron chelation therapy with deferasirox in patients with aplastic anemia: a subgroup analysis of 116 patients from the EPIC trial[J]. Blood, 2010, 116(14):2448-2454. DOI: 10.1182/blood-2010-01-261289.
    [8]
    WOOD JC, ENRIQUEZ C, GHUGRE N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients[J]. Blood, 2005, 106(4):1460-1465. doi: 10.1182/blood-2004-10-3982
    [9]
    MAVROGENI S, KOLOVOU G, BIGALKE B, et al. Transplantation in patients with iron overload: is there a place for magnetic resonance imaging? : transplantation in iron overload[J]. Heart Fail Rev, 2018, 23(2):173-180. DOI: 10.1007/s10741-018-9670-7.
    [10]
    HARRIS AC, YOUNG R, DEVINE S, et al. International, multicenter standardization of acute graft-versus-host disease clinical data collection: a report from the mount sinai acute GVHD international consortium[J]. Biol Blood Marrow Transplant, 2016, 22(1):4-10. DOI: 10.1016/j.bbmt.2015.09.001.
    [11]
    黄蕾, 付蓉.铁过载影响骨髓造血特点及机制研究进展[J].中华血液学杂志, 2019, 40(8):709-712.DOI:10. 3760/cma.j.issn.0253-2727.2019.08.021.

    HUANG L, FU R. Research progress of characteristics and mechanisms of iron overload affecting bone marrow hematopoiesis[J]. Chin J Hema, 2019, 40(8):709-712. DOI: 10.3760/cma.j.issn.0253-2727.2019.08.021.
    [12]
    MCELDUFF A. Iron: how much is too much?[J]. Diabetologia, 2017, 60(2):237-239. DOI: 10.1007/s00125-016-4176-0.
    [13]
    GUPTA R, MUSALLAM KM, TAHER AT, et al. Ineffective erythropoiesis: anemia and iron overload[J]. Hematol Oncol Clin North Am, 2018, 32(2):213-221. DOI: 10.1016/j.hoc.2017.11.009.
    [14]
    TAKAMI A. Hematopoietic stem cell transplantation for acute myeloid leukemia[J]. Int J Hematol, 2018, 107(5):513-518. DOI: 10.1007/s12185-018-2412-8.
    [15]
    FARACI M, BAGNASCO F, LEONI M, et al. Evaluation of chimerism dynamics after allogeneic hematopoietic stem cell transplantation in children with nonmalignant diseases[J]. Biol Blood Marrow Transplant, 2018, 24(5):1088-1093. DOI: 10.1016/j.bbmt.2017.12.801.
    [16]
    MAXIMOVA N, GREGORI M, SIMEONE R, et al. Total body irradiation and iron chelation treatment are associated with pancreatic injury following pediatric hematopoietic stem cell transplantation[J]. Oncotarget, 2018, 9(28): 19543-19554. DOI: 10.18632/oncotarget.24646.
    [17]
    ALVA LC, BACHER U, SEIPEL K, et al. Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia[J]. Transfusion, 2018, 58(10):2365-2373. DOI: 10.1111/trf.14895.
    [18]
    ZHANG X, SHI Y, HUANG Y, et al. Serum ferritin is a different predictor from transfusion history for allogeneic transplantation outcome in patients with severe aplastic anemia[J]. Hematology, 2018, 23(5):291-298. DOI: 10.1080/10245332.2017.1390929.
    [19]
    WERMKE M, ECKOLDT J, GÖTZE KS, et al. Enhanced labile plasma iron and outcome in acute myeloid leukaemia and myelodysplastic syndrome after allogeneic haemopoietic cell transplantation (ALLIVE): a prospective, multicentre, observational trial[J]. Lancet Haematol, 2018, 5(5):e201-e210. DOI: 10.1016/S2352-3026(18)30036-X.
    [20]
    KONG Y, SONG Y, HU Y, et al. Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants[J]. Oncotarget, 2016, 7(21):30892-30906. DOI: 10.18632/oncotarget.8810.
    [21]
    MAXIMOVA N, GREGORI M, BOZ G, et al. MRI-based evaluation of multiorgan iron overload is a predictor of adverse outcomes in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation[J]. Oncotarget, 2017, 8(45):79650-79661. DOI: 10.18632/oncotarget.19021.
    [22]
    SAKAMOTO S, KAWABATA H, KANDA J, et al. High pretransplant hepcidin levels are associated with poor overall survival and delayed platelet engraftment after allogeneic hematopoietic stem cell transplantation[J]. Cancer Med, 2017, 6(1):120-128. DOI: 10.1002/cam4.974.
    [23]
    PULLARKAT V, BLANCHARD S, TEGTMEIER B, et al. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation[J]. Bone Marrow Transplant, 2008, 42(12):799-805. DOI: 10.1038/bmt. 2008.262.
    [24]
    SIVGIN S, BALDANE S, KAYNAR L, et al. Pretransplant serum ferritin level may be a predictive marker for outcomes in patients having undergone allogeneic hematopoietic stem cell transplantation[J]. Neoplasma, 2012, 59(2):183-190. http://www.wanfangdata.com.cn/details/detail.do?_type=perio&id=fb85e90cb716a13a6b3b98c434928cf5
    [25]
    LEITCH HA, FIBACH E, RACHMILEWITZ E. Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies[J]. Crit Rev Oncol Hematol, 2017, 113:156-170. DOI: 10.1016/j.critrevonc.2017.03.002.
    [26]
    OHMOTO A, FUJI S, MIYAGI-MAESHIMA A, et al. Association between pretransplant iron overload determined by bone marrow pathological analysis and bacterial infection[J]. Bone Marrow Transplant, 2017, 52(8):1201-1203. DOI: 10.1038/bmt.2017.93.
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)  / Tables(2)

    Article Metrics

    Article views (214) PDF downloads(21) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return